Half, Actually, whoever did the quarter 2 financial report was well aware of this criteria. Since the Biocurex SEC lawyer send out the late filing notice, I would suspect that the Hart law firm was involved in the change. The filing correctly reflects one license agreement for revenue recognition. Actually, the first quarter report that states there are two license agreements needs to be amended to reflect just one because the amended agreement was signed before the end of the quarter. That is no big deal IMO and I will not make an issue of it.
Half, I doubt if Abbott cares much about what Biocurex does any more.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.